Table 1.
Compd No. | Biochemical LDHA IC50 (nM)a | A673 cells |
MiaPaCa-2 cells |
HEK293 Cells |
|||
---|---|---|---|---|---|---|---|
lactate inh IC50 (nM)a | Cytotox. IC50 (nM)a | lactate inh. IC50 (nM)a | Cytotox. IC50 (nM)a | CETSA IC50(nM)a | |||
1 | 24 | 450 | 2454 | 636 | 8448 | - | |
2 | 25 | 1423 | 4642 | 1721 | 1066 | 501 | |
3 | 36 | 509 | 1959 | 804 | 6195 | 727 | |
4 | 274 | 9719 | 148b | 19400 | 3168b | 15849 | |
5 | 4104 | 20186 | >30000 | 12791 | >30000 | 303 | |
6 | 36 | 1861 | 24440 | 4760 | 17706 | 2529 | |
7 | 2-F | 25 | 613 | 1144 | 867 | 3376 | 150 |
8 | 3-F | 229 | 4465 | 11471 | 6465 | 5747 | - |
9 | H | 23 | 835 | 2647 | 1224 | 8448 | 401 |
10 | F | 23 | 465 | 1344 | 585 | 3416 | 141 |
IC50 values represent the half maximal (50%) inhibitory concentration as determined in the HTS assay using a dose response in the 1536-well format. (n = 2 for lactate and n = 3 for cytotoxicity, CETSA, and biochemical LDHA.)
Efficacy < 20% with curve class 4; therefore, it should be considered as inactive.